Dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat type 2 diabetes mellitus (T2DM) in adults [14, 15]. Here, DPP4 is linked to type 2 diabetes mellitus.